| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000017574 |
| Receipt No. | R000020364 |
| Official scientific title of the study | Efficacy of the Percutaneus Endoscopic Gastrojejunostomy (PEG-J) tube decompression therapy for patients with chronic intestinal pseudo-obstruction (CIPO) |
| Date of disclosure of the study information | 2015/06/01 |
| Last modified on | 2018/10/02 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Efficacy of the Percutaneus Endoscopic Gastrojejunostomy (PEG-J) tube decompression therapy for patients with chronic intestinal pseudo-obstruction (CIPO) | |
| Title of the study (Brief title) | Efficacy of the PEG-J tube decompression therapy for the CIPO patients | |
| Region |
|
|
| Condition | |||
| Condition | Chronic intestinal pseudo-obstruction(CIPO) | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The purpose of this study is to assess the decompression effect of the PEG-J tube in patients with CIPO, and establish the novel treatment available at home. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1) Diameter of the small intestine before and after PEG-J.
2) Frequency of abdominal pain, bloating, and nausea |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Percutaneus endoscopic gastrojejunostomy | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patients who meet the diagnostic criteria for CIPO proposed by Ministry of Health, Labor, and Welfare.
2) Patients of whom written informed consent was obtained. |
|||
| Key exclusion criteria | 1) Patients with organic digestive tract disease.
2) Patients with current or past history of malignant disease. 3) Patients with current other digestive diseases. 4) Patients with psychiatric disorders. 5) Patients judged inappropriate for the trial by investigators. |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Atsushi Nakajima |
| Organization | Yokohama City University School of Medicine |
| Division name | Department of Gastroenterology and Hepatology |
| Address | 3-9 Fukuura Kanazawa-ku, Yokohama, Japan |
| TEL | 045-787-2640 |
| nakajima-tky@umin.ac.jp | |
| Public contact | |
| Name of contact person | Hidenori Ohkubo |
| Organization | Yokohama City University School of Medicine |
| Division name | Department of Gastroenterology and Hepatology |
| Address | 3-9 Fukuura Kanazawa-ku, Yokohama, Japan |
| TEL | 045-787-2640 |
| Homepage URL | |
| ohkuboh@yokohama-cu.ac.jp | |
| Sponsor | |
| Institute | Yokohama City University School of Medicine, Department of Gastroenterology and Hepatology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Grants-in-Aid for Scientific Research of Ministry of Education, Culture, Sports, Science and Technology |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020364 |